iPLATO Chosen in Tech Media Invest Top 100 List

iPLATOiPLATO has earned a place in the Tech Media Invest Top 100, a list of the hottest emerging and most innovative companies in the ever converging tech and media industries. The Top 100 list has been revealed by Europe-Unlimited, Europe's leading event organisers for investors and technology companies, in association with The Guardian, PricewaterhouseCoopers and Kemp Little.

The Tech Media Invest 100 aims to showcase young entrepreneurial companies that are developing innovative new ways to serve business and consumers, and have the potential to radically change the shape of the technology and media industry. The Tech Media Invest Advisory Board felt iPLATO (along with other companies) was an example of the kind of company that may go on to be the leaders of tomorrow.

"Being on the Media Tech Top 100 list is confirmation of the emergence of iPLATO as an exciting business across the innovation spectrum," said Tobias Alpsten Managing Director of iPLATO Healthcare. "Our company provides powerful new services that really make a difference to patients and healthcare professionals around the country. As a unique proposition, our mobile health services deliver measurable health benefits to patients, but they also deliver significant cost savings, making them a valuable choice in the midst of financial challenges for the NHS. iPLATO has more than doubled in size over the last six months, so this popularity is not exactly news to the thousands of healthcare professionals and millions of patients we work with every day. What is new is us emerging as an exciting proposition compared to growth businesses across sectors beyond healthcare."

The Tech Media Invest Advisory Board deployed a detailed process to whittle down a pool of eligible, promising companies to get to the top 100 winners. Evaluations were made on both quantitative and qualitative criteria, such as financial performance, innovation, management, global strategy, and ecosystem integration. The results were moderated by the Board which consisted of some of the UK’s most experienced investors in modern technology and media - a mix of venture capitalists, investment analysts, professional advisers and technology lawyers, who applied their expertise to identify the best performers and the ones to watch.

For information on companies, visit www.e-unlimited.com/tmi

Related news articles:

About Europe-Unlimited
Founded in 1998, privately-owned Europe Unlimited supplies critical business intelligence to innovative technology entrepreneurs, corporations, investors and researchers throughout Europe. Our online community provides a platform to exchange knowledge and to facilitate networking at our pan-European venture events. Over the past decade, our activities have helped thousands of start-ups in finding partners and raising capital. Next to the UK Tech Media 100, we compile the Nordic Venture 50 and the Benelux Venture 50 rankings for the most promising start-ups in these regions, and identify Europe’s leading startups through the Eurecan European Venture Contest, now in its fifth year.

Europe Unlimited coordinated the selection of the UK Tech Media 100 and will organise the forthcoming Tech Media Invest 2009 taking place on October 1st at the Emirates Stadium. For more information, visit www.e-unlimited.com

About iPLATO
iPLATO Healthcare is a London based innovation company dedicated to mobile health since 2006. iPLATO's evidence based mobile health solutions have proven to improve patient access to healthcare, to enable powerful health promotion targeted at people at risk and to support people with long term conditions.

Serving millions of patients and thousands of healthcare professionals every day iPLATO has emerged as the leader in mobile health. Across this network the company is running campaigns to promote smoking cessation, weight loss, childhood immunisation and pandemic awareness as well as mobile disease management services for people with diabetes, hypertension, epilepsy and HIV.

iPLATO Healthcare's mission is to, in partnership with healthcare professionals and provider organisations, support patients in achieving longer, healthier lives.

Most Popular Now

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...